Sponsor Dossier
AFT Pharmaceuticals
Sponsor Dossier for AFT Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AFT PHARMACEUTICALS
- Brand: ALLERCLEAR
- Brand: Allersoothe
- Brand: ANTIZOL
- Brand: ARSENIC TRIOXIDE-AFT
- Brand: ATENOLOL-AFT
- Brand: AZITHROMYCIN-AFT
- Brand: BORTEZOMIB-AFT
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
- Device (sponsor): Multi-purpose saline solution
- Device (sponsor): Eye heat therapy pack
- Device (sponsor): Woven gauze pad, sterile
- Device (sponsor): Adhesive tape, general-purpose
- Device (sponsor): Bandage, <specify>
- Device (sponsor): Adhesive tape, general-purpose
- Device (sponsor): Home-use dry eye therapy kit
- Device (sponsor): Mask, surgical, single use
- Device (sponsor): Intestinal mucosa barrier
- Device (sponsor): Compress, hot/cold pack, reusable
- Device (sponsor): Burn gel, sterile
- Device (sponsor): Lubricant, eye
- Device (sponsor): Adhesive strip, skin-cover
- Device (sponsor): First aid kit, non-medicated, reusable
- Device (sponsor): Woven gauze pad, sterile
- Device (sponsor): Non-woven gauze pad, sterile
- Device (sponsor): Glove, <specify>
- Device (sponsor): Bandage, <specify>
- Device (sponsor): Tweezers, <specify>
- Device (sponsor): Adhesive tape, general-purpose
- Device (sponsor): Skin-cleaning wipe, non-sterile
- Device (sponsor): Scissors, <specify>
- Device (sponsor): Dispenser, medication, <specify>
- Device (sponsor): Cold pack, reusable
About
AFT Pharmaceuticals is an Australian Private Company with ABN 29105636413, registered in NSW. The company is currently active on the Australian Business Register.
Portfolio
AFT Pharmaceuticals has 112 brands on the ARTG, of which 70 are indexable and 63 carry a Product Information document. 24 brands are PBS-listed, 4 have a PBAC outcome on record, and 2 have an AusPAR on record. Notable brands include AFT PHARMACEUTICALS, ALLERCLEAR, Allersoothe, ANTIZOL, ARSENIC TRIOXIDE-AFT, ATENOLOL-AFT, AZITHROMYCIN-AFT, BORTEZOMIB-AFT, BURINEX, CALCI-TAB, Calcitriol-AFT,, CANDACORT.
Therapeutic focus
— Infectious Disease: 18 brands — Pain Management: 14 brands — Gastroenterology: 11 brands — Dermatology: 9 brands — Oncology: 8 brands — Haematology: 7 brands — Neurology: 6 brands — Cardiology: 6 brands — Complementary Medicine: 6 brands — Other: 6 brands — Ophthalmology: 5 brands — Respiratory: 4 brands — Reproductive Health: 4 brands — Psychiatry: 2 brands — Immunology: 2 brands — Musculoskeletal: 2 brands — Endocrinology: 1 brand — Renal: 1 brand
PBS footprint
24 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-03-01, across 4 brands with a PBAC outcome on record. The latest AusPAR is 2025-08-18, across 2 brands with an AusPAR on record.